Real-world drug survival and treatment outcome of ixekizumab in patients with spondyloarthropathies
BackgroundChronic inflammatory rheumatic diseases, such as ankylosing spondylitis, psoriatic arthritis, reactive arthritis, and enteropathic arthritis, are collectively referred to as spondyloarthropathies (SpA). However, Real-world evidence on the eff…